Neuropathy affects millions of people worldwide, causing chronic pain, numbness, weakness, and loss of function in the ...

An estimated 1 in 10 people worldwide have diabetes. Africa is the region with the fastest growth and it's estimated that the ...

A new study led by University of Calgary professor Dr. Tuan Trang, Ph.D., may help to explain why there are more women ...

MIRA Pharmaceuticals signs letter of intent to acquire SKNY Pharmaceuticals, adding SKNY-1, a preclinical drug for weight ...

MIRA Pharmaceuticals unveils Ketamir-2 topical for neuropathic pain, complementing its oral version. Clinical and preclinical ...

A new study led by University of Calgary researchers may help to explain why there is an over-representation of women ...

New research reveals why women experience chronic pain more frequently than men, uncovering key biological differences in pain processing.

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the successful ...

Neural foraminal stenosis causes nerve irritation and compression when the space a spinal nerve travels through narrows.

A new study may help to explain why there is an over-representation of women experiencing chronic pain compared to men and why pain medication may not be as effective for women as it is for men.

This advancement expands the Company's pain management portfolio beyond its ongoing Ketamir-2 oral treatment for neuropathic pain, offering a novel, targeted approach for localized pain relief.